Complement is crucial in the pathogenesis of ANCA-associated vasculitis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23271485.
- Also identified by DOI 10.1038/ki.2012.371.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Renal lesions in ANCA-associated vasculitis (AAV) show an absence or paucity of immune deposits. Therefore, complement was not considered a major pathogenic factor. Data from an animal model of AAV, however, suggest involvement of the alternative pathway of complement. The paper by Gou et al. demonstrates activation also of the alternative and final common pathways in patients with AAV. Thus, the complement system might be a target for treatment in human AAV.
Medical subject headings
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- Complement Activation
- Complement Factor B
- Severity of Illness Index